COVID LEGACY: A New Era For Clinical Trials?

In the last fifteen months both individuals and organizations have had to change their behaviors. It’s typically meant more activity being done remotely, requiring greater agility and pace to deliver against changing demand, with technology often being deployed to overcome the unique challenges the pandemic has posed. Read More

Breaking down the barriers to just-in-time labeling

The COVID-19 pandemic has increased pressures across the medical device and clinical trial industries. Flexibility throughout all aspects of the supply chain has never been more valuable. Read More